Comment on

• Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

  Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, Feuer EJ, de Koning HJ, Mariotto AB, Etzioni R. Tsodikov A, et al. Ann Intern Med. 2017 Oct 3;167(7):449-455. doi: 10.7326/M16-2586. Epub 2017 Sep 5. Ann Intern Med. 2017. PMID: 28869989 Free PMC article.
• Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

  Autier P, Boyle P. Autier P, et al. Ann Intern Med. 2018 Apr 17;168(8):606. doi: 10.7326/L17-0733. Ann Intern Med. 2018. PMID: 29677257 No abstract available.
• Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

  Luh JY, Finkelstein SE, Michalski JM, Sandler H. Luh JY, et al. Ann Intern Med. 2018 Apr 17;168(8):607-608. doi: 10.7326/L17-0734. Ann Intern Med. 2018. PMID: 29677258 No abstract available.
• Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

  Prorok PC, Miller AB. Prorok PC, et al. Ann Intern Med. 2018 Apr 17;168(8):605-606. doi: 10.7326/L17-0735. Ann Intern Med. 2018. PMID: 29677259 No abstract available.
• Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

  Baker SG. Baker SG. Ann Intern Med. 2018 Apr 17;168(8):606-607. doi: 10.7326/L17-0736. Ann Intern Med. 2018. PMID: 29677260 No abstract available.
• Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

  Tokudome S, Ando R, Hashimoto S. Tokudome S, et al. Ann Intern Med. 2018 Apr 17;168(8):608. doi: 10.7326/L17-0737. Ann Intern Med. 2018. PMID: 29677261 No abstract available.